Bibliography
- DANYSZ W, PARSONS CG, BRESINK I, QUACK G: Glutamate in CNS Disorders. Drugs News Persp. (1995) 8(5):261–277.
- •Thorough review focused AMPA and NMDA ionotropic glu-tamate receptors.
- CUNNINGHAM MD, FERKANY JW, ENNA SJ: Excitatory amino acid receptors: a gallery of new targets for phar-macological intervention. Life Sci. (1994) 54 (3):135–148.
- CROUCHER MJ, COLLINS JF, MELDRUM BS: Anticonvul-sant action of excitatory amino acid antagonists. Sci-ence (1982) 216:899–901.
- LEESON PD, IVERSEN LL: The glycine site on the NMDA receptor: structure-activity relationships and thera-peutic potential. J. Med. Chem. (1994) 37: 4053–4067.
- •Detailed analysis of the glycine site on the NMDA receptor.
- SHEARDOWN MS, NIELSEN EO, HANSEN AJ, JACOBSEN P,HONORÉ T: 2,3-Dihydro-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science (1990) 247:571–574.
- OHMORI J, SHIMIZU-SASAMATA M, OKADA M, SAKA-MOTO S: Novel AMPA receptor antagonists : synthesis and structure-activity relationships of 1-hydroxy-7- (1H-imidazol-1-y1)-6-nitro-2,3 (1H,4H)-quinoxalin-edione and related compounds . J. Med. Chem. (1996) 39:3971–3979.
- LUBISH W, BEHL B, HOFMANN HP: Pyrrolyl-quinoxalinediones: a new class of AMPA receptor an-tagonists. Bioorg. Med. Chem. Lett. (1996) 6(23)2887–2892.
- XIONG CAI S, KHER SN, ZHOU Z-L et al: Structure-activity relationships of alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemi-cally active antagonists for the glycine site of the NMDA receptor. J. Med. Chem. (1997) 40:730–738.
- WOODWARD RM, HUETTNER JE, GUASTELLA J, KEANAJFW, WEBER E: In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinedio-nes with high affinity and selectivity for N-methyl-n-a-spartate receptor glycine site. Mol. Pharmacol (1995) 47:568–581.
- EPPERSON JR, HEWAWASAM P, MEANWELL NA, BOIS-SARD CG, GRIBKOFF VK, POST-MUNSON D: Synthesis and excitatory amino acid pharmacology of some novel quinoxalinediones. Bioorg. Med. Chem. Lett. (1993) 3(12):2801–2804.
- XUE D, HUANG ZG, BARNES K, LESIUK HJ, SMITH KE, BU-CHAN AM: Delayed treatments with AMPA, but not NMDA antagonists reduces neocortical infarction. J. Cerebr. Blood Flow Metab. (1994) 14(2):251–261.